The gene fusions discovered could potentially serve as a marker one day for diagnosing cancer or as a target for future drug development.
January 14, 2009: A tiny particle syringe composed of polymer layers and nanoparticles may provide drug delivery that targets diseased cells without harming the rest of the body, according to a team of chemical engineers. This delivery system could be robust and flexible enough to deliver a variety of substances.